CNBC   |  January 23, 2013

Aegerion CEO on Promise of Biopharma

Marc Beer, Aegerion Pharmaceuticals CEO, discusses a drug in the company's pipeline that treats patients with severe cholesterol disorder.

Share This:

Sorry, we do not have a transcript available for this video at this time.